Ocugen Inc is trading at $1.24 (+5.08%) following a sharp intraday rebound, though the exact catalyst for the move remains unclear.
- No major company-specific announcements, earnings updates, FDA decisions, or analyst actions were identified in available sources.
- The stock's performance is notably stronger than the broader market, which remains mixed rather than decisively risk-on.